Liothyronine Sodium
NDC 68788-7269, Liothyronine Sodium, tablet, from Preferred Pharmaceuticals Inc..
- Product NDC
- 68788-7269
- Status
- Listed
- Labeler
- Preferred Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200295
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7269 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM5 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68788-7269-3 | 68788726903 | 30 TABLET in 1 BOTTLE (68788-7269-3) |
| 68788-7269-6 | 68788726906 | 60 TABLET in 1 BOTTLE (68788-7269-6) |
| 68788-7269-9 | 68788726909 | 90 TABLET in 1 BOTTLE (68788-7269-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/57744c7c-af44-4bc4-a5a8-79f05710f469
Use it
Look up 68788-7269 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7269 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68788-7269. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.